fluxd.news

LIVE

Fintech

Biogen Taps Alloy Platform To Push Antisense Drug Pipeline Forward

Benzinga·April 7, 2026 at 12:54 PM

Biogen partners with Alloy Therapeutics to advance antisense therapies using RNA-targeting technology, expanding its pipeline.

Original Source

Benzinga — www.benzinga.com

Related in Fintech

Consumers Pull Back on Credit Card Spending
PYMNTS
CZ recounts SBF's desperate FTX collapse requests
CoinDesk
Bitcoin Surges Past $72,000 on Ceasefire News
CoinDesk
Legion Health AI Gets Utah Approval for Prescription Refills
PYMNTS

Biogen Taps Alloy Platform To Push Antisense Drug Pipeline Forward · fluxd.news